Navigation Links
3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
Date:8/24/2010

s-releases/health-latest-news/medical-pharmaceuticals-list">Medical Pharmaceuticals, Pharmaceuticals, Contracts Click to view news release full screen  

3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China

 

SHENYANG, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc. ("Isotechnika") (TSX: ISA), a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.

Under the terms of the agreement, Isotechnika will grant 3SBio exclusive rights to all transplant and autoimmune indications of voclosporin in China, including Hong Kong and Taiwan, excluding ophthalmic indications and medical devices which were previously licensed to Lux Biosciences, Inc. and Atrium Medical Corporation, respectively. 3SBio will be responsible for the clinical development, registration and commercialization of voclosporin in China. Isotechnika will provide, under separate agreement, commercial supply to 3SBio on a cost-plus basis. Isotechnika will rece
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. 3SBio Inc. Announces Results of Annual General Meeting
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... present at the CL King 13 th Annual ... at 11:00 a.m. ET. The conference will be held ... New York City . Abaxis, Inc. ...
(Date:9/3/2015)... Sept. 3, 2015  VirtualScopics, Inc. (NASDAQ: ... imaging solutions, announced today, they are collaborating with ... new philanthropic, epidemiology study partnering with the Ministry ...  VirtualScopics has teamed up with a cardiac sonographer ... image results will be used to identify children ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and ... of the "Investigation Report on China,s Levothyroxine ... Thyroid hormones (TH) have the greatest ... younger ones. Without thyroid hormones mainly promote the ... organs, even the growth hormone (GH) of pipuitary ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4Investigation Report on China's Levothyroxine Market, 2010-2019 2
... , CRANBURY, N.J. , Feb. 9 ... announced the completion of first cohort dosing in a placebo-controlled, ... dysfunction.  The primary endpoint in this double-blind safety study is ... between 45 and 65 years old.  The study will also ...
... , SAN MATEO, Calif. , ... the leader in high quality 3D Cone Beam Imaging systems for ... as Director of Marketing. , PreXion President/COO Robert Meier ... management team and I look forward to working with him in ...
Cached Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4PreXion, Inc. Announces Appointment of Director of Marketing 2
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
(Date:9/4/2015)... ... 2015 , ... FiltersFast.com, the online retail leader in air ... up. FiltersFast.com, will ship all orders over $50.00 for free. Use this ... advantage of this promotion now through September 8, 2015. , Filtersfast.com offers a ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to ... is the norm not the exception. , St. Jude was recently named one of ... Stroke Association, making it one of only 10 hospitals in the state to earn ...
(Date:9/3/2015)... ... 2015 , ... E-Volve Health, an Elliot Health System Company, ... to provide electronic medical record (EMR) consulting services to Amerinet clients running or ... pricing on E-Volve Health’s Epic EMR consulting, custom training and support services. E-Volve ...
(Date:9/3/2015)... ... , ... BedJet released a new version of its award winning personal climate ... BedJet v2 pre-order campaign blazed past the $1 million dollar mark in ... crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the award winning BedJet ...
Breaking Medicine News(10 mins):Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3
... insights about how a bacterium uses different receptors to sense ... in environments of the order of 0.1%, approximating to a ... ,New Cornell research, highlighted on the cover of ... that receptors assemble into a kind of cooperative lattice on ...
... had suffered pneumonia eight times and experienced recurring pass-outs, had ... sense of the symptoms and providing answers. When the X-rays ... Kirchen that the symptoms may be signs of lung cancer. ... a respiratory physician, stumbled upon a nut, safely ensconced in ...
... of a nap, which follows after eating (traditionally called European ... due to changes in glucose levels//. ,Brain cells ... well as in animals become switched off after eating, and ... researchers at Manchester University finds. ,A tiny protein ...
... adult and two children have been diagnosed with the E.coli 0157 ... there have been three linked cases of E.coli 0157 within the ... a link with J&H Cairns, a butcher in the village. ... yet that J&H Cairns is the source of the outbreak, they ...
... (FGM) are significantly more likely to experience difficulties during childbirth ... result of the gruesome practice, a new United Nations study ... clear evidence of the harmful effects for women and children, ... million women worldwide., ,The serious complications during childbirth it ...
... admitted in a private hospital here in a serious condition, ... , today showed signs of improvement with all his vital ... conditon. His oxygen level and blood pressure are normal,' said ... in the wee hours., ,The doctors are also going ...
Cached Medicine News:Health News:Study Highlights How Bacteria Respond To Changes In Environment 2Health News:Diagnosis On a Fourth Patient Confirmed To Be E.Coli 2
... Advantage delivers higher magnification for advanced surgical ... image, even at the highest magnification. 3.5x, ... and precise color rendition is ideal for ... anti-reflective coating produce a superior image. The ...
... up of doublet objective and high power ... and 3.0x. The true benefit of this ... maintaining focal clarity is made possible due ... ultra lightweight aluminum bar and individual interpupillary ...
Used for maintaining and forming the anterior chamber by the injection and removal of fluids, air miotics, and viscoeastic substances, as well as keeping the cornea moist during surgery. 4 mm from be...
23 gauge cannula (E4969 L) with 0.33 mm aspiration port, curved shaft and polished finish. Includes Teflon irrigating sleeve (E4969 SL). Uses 60 cm (23.6 inches) of silicone tubing (N5941 5). Overall...
Medicine Products: